Efficacy and Safety of Intense Pulsed Light With a KTP/PDLlike Filter for the Treatment of Facial Telangiectasias
Overview
Affiliations
Background: An intense pulsed light (IPL) narrowband "KTP/PDL-like" filter (525–585 nm) may combine the tolerability of the IPL with the precision of KTP and PDL lasers. This study evaluated the impact of IPL with a KTP/PDL-like filter on telangiectasias.
Methods: This was a single-center, prospective study of 17 subjects with facial telangiectasias and skin types I–III. Three monthly treatments were performed using this specific filter, with follow-up visits at 1, 3, and 6 months. Telangiectasia improvement was assessed by the investigator and subjects using a 5-point scale. Facial photographs and safety assessments were obtained at each visit. Subject discomfort was evaluated using a visual analog scale (VAS) immediately posttreatment, and subject downtime was recorded at each subsequent visit.
Results: All facial telangiectasias significantly improved. At 1-month follow-up, >50% lesion clearance was noted in 97.1% of facial (n=36) and 85.7% of non-facial (n=7) lesions, with 73% of subjects satisfied or very satisfied. An increase in mean social downtime (0, 2.3, and 3 days) and VAS scores (3.5, 4.5, and 4.8) with treatments 1, 2, and 3, respectively, mirrored a stepwise increase in fluence with subsequent sessions.
Conclusions: The use of a novel IPL narrowband KTP/PDL-like filter can significantly improve facial and non-facial telangiectasias with minimal downtime. J Drugs Dermatol. 2020;19(9):844-850. doi:10.36849/JDD.2020.4834.
Piccolo D, Fusco I, Zingoni T, Conforti C J Clin Med. 2024; 13(6).
PMID: 38541871 PMC: 10970793. DOI: 10.3390/jcm13061646.
[Expert consensus on the clinical application of narrow-band intense pulsed light (2024 edition)].
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2024; 40(1):19-25.
PMID: 38296233 PMC: 11630202. DOI: 10.3760/cma.j.cn501225-20230918-00085.
Bennardo L, Patruno C, Zappia E, Tamburi F, Sannino M, Negosanti F Medicina (Kaunas). 2022; 58(5).
PMID: 35630068 PMC: 9147706. DOI: 10.3390/medicina58050651.